Medicine information
Uses & overview
VILDIABATE 50 by Steris Healthcare delivers 50 mg of Vildagliptin in a single, easy-to-swallow tablet. As a selective and potent DPP-4 inhibitor, VILDIABATE 50 optimizes pancreatic islet cell responsiveness, enhancing natural insulin secretion while suppressing inappropriate glucagon release without causing weight gain or sudden blood sugar drops. Key Uses & Clinical Benefits: Effective Glycemic Control: Helps lower both fasting and postprandial (post-meal) blood glucose levels to assist patients in reaching target HbA1c goals. Incretin Enhancement: Selectively inhibits the DPP-4 enzyme, prolonging the activity of naturally occurring incretin hormones (GLP-1 and GIP) that stimulate insulin release after meals. Glucose-Dependent Mechanism: Stimulates insulin secretion from pancreatic beta cells and suppresses glucagon from alpha cells only when blood glucose levels are elevated, providing high therapeutic safety. Low Risk of Hypoglycemia: Works in response to glucose elevation, making it highly reliable as monotherapy or when combined with Metformin. Weight-Neutral Profile: Does not cause body weight gain, making it an ideal choice for long-term daily glycemic management. How VILDIABATE 50 Works: Vildagliptin binds selectively to the DPP-4 enzyme, preventing the rapid degradation of active incretin hormones. Increased incretin levels improve pancreatic beta-cell sensitivity to glucose, leading to increased mealtime insulin synthesis and reduced hepatic glucagon output.
How to use
Take 1 tablet of VILDIABATE 50 once or twice daily (as prescribed), with or without food, or strictly as directed by your physician. Swallow the tablet whole with a glass of water. Do not crush, chew, or break the tablet. Try to take it at the same time every day to maintain consistent therapeutic drug levels.
Storage
Store in a cool, dry place away from direct sunlight, light, and moisture. Store at a controlled room temperature below 30°C. Keep out of reach and sight of children.
